Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132174) titled 'Prognostic impact of thymosin in sepsis patients with immunosuppression: a clinical study' on Sept. 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Jiangdu People's Hospital Affiliated to Yangzhou University
Condition:
Sepsis, immunosuppressive state
Intervention:
Non-thymosin control group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-10
Target Sample Size: Non-thymosin control group:150;Thymosin treatment group:150;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=342751
Publ...